Columbia Care Inc
Change company Symbol lookup
Select an option...
CCHWF Columbia Care Inc
VGI Virtus Global Multi-Sector Income Fund
FRME First Merchants Corp
V Visa Inc
VRAY ViewRay Inc
LLAP Terran Orbital Corp
RTX Raytheon Technologies Corp
PLUG Plug Power Inc
PNM PNM Resources Inc
PFE Pfizer Inc
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Columbia Care Inc. is a cultivator, manufacturer and provider of cannabis products and related services. The Company’s principal business activity is the production and sale of cannabis. The Company operates approximately 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities. The Company offers products such as spanning flower, edibles, oils, and tablets. It manufactures brands which include Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label Cannabidiol (CBD). The Company, through its subsidiaries, owns or manages interests in state-licensed medical and/or adult use marijuana businesses in Arizona, California, Colorado, Delaware, European Union, Florida, Illinois, Maryland, Massachusetts, Missouri, New Jersey, New York and Puerto Rico, among others. The Company’s subsidiaries include 203 Organix, L.L.C., Columbia Care - Arizona, Tempe, L.L.C., Columbia Care-Arizona, Prescott, L.L.C. and Salubrious Wellness Clinic, Inc.

Closing Price
$0.63
Day's Change
-0.045 (-6.67%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.69
Day's Low
0.625
Volume
(Heavy Day)
Volume:
739,310

10-day average volume:
436,734
739,310

Company Profile

Columbia Care Inc. is a cultivator, manufacturer and provider of cannabis products and related services. The Company’s principal business activity is the production and sale of cannabis. The Company operates approximately 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities. The Company offers products such as spanning flower, edibles, oils, and tablets. It manufactures brands which include Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label Cannabidiol (CBD). The Company, through its subsidiaries, owns or manages interests in state-licensed medical and/or adult use marijuana businesses in Arizona, California, Colorado, Delaware, European Union, Florida, Illinois, Maryland, Massachusetts, Missouri, New Jersey, New York and Puerto Rico, among others. The Company’s subsidiaries include 203 Organix, L.L.C., Columbia Care - Arizona, Tempe, L.L.C., Columbia Care-Arizona, Prescott, L.L.C. and Salubrious Wellness Clinic, Inc.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
0.51x
Price/Book (MRQ)
2.13x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

No short interest available.

Share Information

CCHWF is in a share class of common stock
Float
343.2M
Shares Outstanding
391.2M
Institutions Holding Shares
24
2.12%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

No company officers listed.

Address

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.